SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Andrykowski MA, Cordova MJ, Hann DH, Jacobsen PB, Fields KK, Phillips G. Patients' psychosocial concerns following stem cell transplantation. Bone Marrow Transplant. 1999; 24: 11211129.
  • 2
    Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005; 104: 25652576.
  • 3
    Fox SW, Lyon DE. Symptom clusters and quality of life in survivors of lung cancer. Oncol Nurs Forum. 2006; 33: 931936.
  • 4
    Loge JH, Ekeberg O, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res. 1998; 45: 5365.
  • 5
    Watt T, Groenvold M, Bjorner JB, Noerholm V, Rasmussen NA, Bech P. Fatigue in the Danish general population. Influence of sociodemographic factors and disease. J Epidemiol Community Health. 2000; 54: 827833.
  • 6
    Fuhrer R, Wessely S. The epidemiology of fatigue and depression: a French primary-care study. Psychol Med. 1995; 25: 895906.
  • 7
    Bower JE, Ganz PA, Desmond KA, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006; 106: 751758.
  • 8
    Donovan KA, Jacobsen PB, Andrykowski MA, et al. Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. J Pain Symptom Manage. 2004; 28: 373380.
  • 9
    Hwang SS, Chang VT, Rue M, Kasimis B. Multiple independent predictors of cancer-related fatigue. J Pain Symptom Manage. 2003; 26: 604614.
  • 10
    Andrykowski MA, Curran SL, Lightner R. Off treatment fatigue in breast cancer survivors: a controlled comparison. JBehav Med. 1998; 21: 118.
  • 11
    Broeckel JA, Jacobsen PB, Horton JH, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998; 16: 16891696.
  • 12
    Hann DH, Jacobsen P, Azzarello L, Greenberg H. Fatigue and quality of life following radiotherapy for breast cancer: a comparative study. J Clin Psychol Med Settings. 1998; 5: 1933.
  • 13
    Robb C, Haley WE, Balducci L, et al. Impact of breast cancer survivorship on quality of life in older women. Crit Rev Oncol/Hematol. 2007; 62: 8491.
  • 14
    Tomich PL, Helgeson VS. Five years later: a cross-sectional comparison of breast cancer survivors with healthy women. Psychooncology. 2002; 11: 154169.
  • 15
    Talbott EO, Norman SA, Baffone KM, et al. Selection of neighborhood controls for a study of factors related to the diagnosis of cervical cancer. J Clin Epidemiol. 1993; 46: 12771287.
  • 16
    Helgeson VS, Tomich PL. Surviving cancer: a comparison of 5-year disease-free breast cancer survivors with healthy women. Psychooncology. 2005; 14: 307317.
  • 17
    Helgeson VS, Cohen S, Schulz R, Yasko J. Educational and peer discussion group interventions and adjustment to breast cancer. Arch Gen Psychiatry. 1999; 56: 340347.
  • 18
    Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000; 18: 743753.
  • 19
    Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC. Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum. 1998; 25: 915920.
  • 20
    Hann DH, Jacobsen PB, Azzarello LM, et al. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res. 1998; 7: 301310.
  • 21
    McNair DM, Lorr M, Droppleman L. Profile of Mood States Manual. San Diego: Educational and Industrial Testing Service; 1971.
  • 22
    Taylor MJ, Heaton RK. Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factors scores in neuropsychological assessment. J Int Neuropsychol Soc. 2001; 7: 867874.
  • 23
    Schafer JL. Analysis of incomplete multivariate data. New York: Chapman and Hall; 1997.
  • 24
    Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999; 48: 15311548.
  • 25
    Wilson IB. Clinical understanding and clinical implications of response shift. Soc Sci Med. 1999; 48: 15771588.
  • 26
    Jansen SJ, Stiggelbout AM, Nooij MA, Noordijk EM, Kievit J. Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy. Qual Life Res. 2000; 9: 603615.
  • 27
    Visser MR, Smets EM, Sprangers MA, de Haes HJ. How response shift may affect the measurement of change in fatigue. J Pain Symptom Manage. 2000; 20: 1218.
  • 28
    Donovan KA, Small BJ, Andrykowski MA, Munster P, Jacobsen PB. Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychol. 2007; 26: 464472.
  • 29
    Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003; 21: 16601668.
  • 30
    Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002; 64: 604611.
  • 31
    Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res. 2006; 12: 27592766.